Angela N. Koehler

5.6k total citations · 2 hit papers
59 papers, 4.1k citations indexed

About

Angela N. Koehler is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Angela N. Koehler has authored 59 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 14 papers in Organic Chemistry and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Angela N. Koehler's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Protein Degradation and Inhibitors (13 papers) and Advanced Biosensing Techniques and Applications (13 papers). Angela N. Koehler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Protein Degradation and Inhibitors (13 papers) and Advanced Biosensing Techniques and Applications (13 papers). Angela N. Koehler collaborates with scholars based in United States, South Korea and Portugal. Angela N. Koehler's co-authors include Stuart L. Schreiber, Matthew J. Henley, Gavin MacBeath, Paul A. Clemons, Jay Duffner, Alykhan F. Shamji, Carlos Tassa, Mary Kathryn Doud, Bridget K. Wagner and Stephen J. Haggarty and has published in prestigious journals such as Science, Cell and Chemical Reviews.

In The Last Decade

Angela N. Koehler

55 papers receiving 4.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling

2009 635 citations Angela N. Koehler, Mary Kathryn Doud et al. profile →
Advances in targeting ‘undruggable’ transcription factors with small molecules

2021 248 citations Matthew J. Henley, Angela N. Koehler Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela N. Koehler United States	30	3.1k	714	647	415	355	59	4.1k
Oded Livnah Israel	35	2.2k 0.7×	549 0.8×	519 0.8×	520 1.3×	159 0.4×	84	4.2k
Lin Jiang United States	30	4.0k 1.3×	452 0.6×	233 0.4×	313 0.8×	157 0.4×	52	5.6k
Jörg Benz Switzerland	34	2.8k 0.9×	635 0.9×	689 1.1×	296 0.7×	172 0.5×	67	4.3k
Ronald W. Barrett United States	28	3.6k 1.1×	1.2k 1.7×	1.5k 2.3×	354 0.9×	160 0.5×	59	5.4k
Luciana Marinelli Italy	43	3.1k 1.0×	1.2k 1.6×	473 0.7×	912 2.2×	89 0.3×	164	5.1k
Kavita Shah United States	43	3.7k 1.2×	1.2k 1.7×	168 0.3×	824 2.0×	221 0.6×	107	6.0k
Indraneel Ghosh United States	31	2.7k 0.9×	454 0.6×	307 0.5×	218 0.5×	168 0.5×	64	3.5k
George D. Hartman United States	40	2.5k 0.8×	1.7k 2.4×	319 0.5×	508 1.2×	146 0.4×	183	5.4k
Pavel Majer Czechia	31	1.6k 0.5×	565 0.8×	418 0.6×	640 1.5×	109 0.3×	117	3.3k
Per Hammarström Sweden	45	4.5k 1.4×	381 0.5×	167 0.3×	361 0.9×	218 0.6×	145	7.2k

Countries citing papers authored by Angela N. Koehler

Since Specialization

Citations

This map shows the geographic impact of Angela N. Koehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela N. Koehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela N. Koehler more than expected).

Fields of papers citing papers by Angela N. Koehler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela N. Koehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela N. Koehler. The network helps show where Angela N. Koehler may publish in the future.

Co-authorship network of co-authors of Angela N. Koehler

This figure shows the co-authorship network connecting the top 25 collaborators of Angela N. Koehler. A scholar is included among the top collaborators of Angela N. Koehler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela N. Koehler. Angela N. Koehler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Zhongqiu, et al.. (2026). A first-in-class small-molecule inhibitor targeting AVIL exhibits safety and antitumor efficacy in preclinical models of glioblastoma. Science Translational Medicine. 18(834). eadt1211–eadt1211.

Koehler, Angela N., et al.. (2025). At The Interface: Small-Molecule Inhibitors of Soluble Cytokines. Chemical Reviews. 125(9). 4528–4568. 1 indexed citations

Oberoi, Sapna, et al.. (2025). Towards directed therapy for fusion-positive rhabdomyosarcoma. Pharmacology & Therapeutics. 276. 108931–108931.

Calo, Eliezer, et al.. (2025). Chemical Probe Discovery for DEAD-Box RNA-Binding Protein DDX21 Using Small-Molecule Microarrays. ACS Chemical Biology. 20(8). 1928–1938.

Cui, Huarui, et al.. (2024). Small-Molecule Approaches to Target Transcription Factors. 8(1). 395–415. 5 indexed citations

Deutzmann, Anja, Delaney K. Sullivan, Renumathy Dhanasekaran, et al.. (2024). Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma. Nature Communications. 15(1). 963–963. 8 indexed citations

Koehler, Angela N., et al.. (2023). Addressing Transcriptional Dysregulation in Cancer through CDK9 Inhibition. Biochemistry. 62(6). 1114–1123. 12 indexed citations

Boehnke, Natalie, Joelle P. Straehla, Hannah C. Safford, et al.. (2022). Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science. 377(6604). eabm5551–eabm5551. 136 indexed citations

Henley, Matthew J. & Angela N. Koehler. (2021). Advances in targeting ‘undruggable’ transcription factors with small molecules. Nature Reviews Drug Discovery. 20(9). 669–688. 248 indexed citations breakdown →

10.

Richters, André, et al.. (2018). An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives. Methods in enzymology on CD-ROM/Methods in enzymology. 610. 191–218.

11.

Yang, Zhihong, Angela N. Koehler, & Li Wang. (2016). A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2. Molecular Cancer Therapeutics. 15(10). 2294–2301. 45 indexed citations

12.

Zhang, Zhengjian, Žarko Bošković, Mahmud M. Hussain, et al.. (2015). Chemical perturbation of an intrinsically disordered region of TFIID distinguishes two modes of transcription initiation. eLife. 4. 39 indexed citations

13.

Pop, Marius S., et al.. (2015). Advances in discovering small molecules to probe protein function in a systems context. Current Opinion in Chemical Biology. 30. 28–36. 12 indexed citations

14.

Pop, Marius S., Nicolas Stransky, Colin W. Garvie, et al.. (2014). A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein. Molecular Cancer Therapeutics. 13(6). 1492–1502. 49 indexed citations

15.

Sadaghiani, Amir Masoud, Sang Min Lee, Justin I. Odegaard, et al.. (2014). Identification of Orai1 Channel Inhibitors by Using Minimal Functional Domains to Screen Small Molecule Microarrays. Chemistry & Biology. 21(10). 1278–1292. 53 indexed citations

16.

Kemp, Melissa M., Qiu Wang, Nathan West, et al.. (2011). A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold. Bioorganic & Medicinal Chemistry Letters. 21(14). 4164–4169. 19 indexed citations

17.

Clemons, Paul A., Nicole E. Bodycombe, Joshua Wilson, et al.. (2010). Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proceedings of the National Academy of Sciences. 107(44). 18787–18792. 280 indexed citations

18.

Vegas, Arturo J. & Angela N. Koehler. (2010). Detecting Protein–Small Molecule Interactions Using Fluorous Small-Molecule Microarrays. Methods in molecular biology. 669. 43–55. 2 indexed citations

19.

Ong, Shao‐En, Monica Schenone, Adam A. Margolin, et al.. (2009). Identifying the proteins to which small-molecule probes and drugs bind in cells. Proceedings of the National Academy of Sciences. 106(12). 4617–4622. 237 indexed citations

20.

Barnes‐Seeman, David, Seung Bum Park, Angela N. Koehler, & Stuart L. Schreiber. (2003). Expanding the Functional Group Compatibility of Small‐Molecule Microarrays: Discovery of Novel Calmodulin Ligands. Angewandte Chemie International Edition. 42(21). 2376–2379. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact